Rogers Corp. ROG

NYS: ROG | ISIN: US7751331015   13/10/2025
84,57 USD (+3,68%)
(+3,68%)   13/10/2025

13 oktober 2025 · Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology · Persbericht

25 juli 2024 · Roche showcases solutions for laboratories of the future at the Association for Diagnostics & Laboratory Medicine 2024 Clinical Lab Expo · Persbericht

5 september 2023 · Economist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare · Persbericht

27 juni 2023 · Roche receives FDA clearance for additional Alzheimer's disease Cerebrospinal Fluid (CSF) assays, supporting timely diagnosis and treatment decision-making · Persbericht

11 april 2023 · Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care · Persbericht

30 september 2022 · DuPont and Rogers Provide Update on Pending Merger · Persbericht

8 februari 2022 · DuPont Reports Fourth Quarter and Full Year 2021 Results · Persbericht

3 januari 2022 · Moore Kuehn Encourages QDEL, SEAC, ROG, and VG Investors to Contact Law Firm · Persbericht

30 november 2021 · URGENT: The M&A Firm is Investigating the Sale of Rogers Corp. - ROG · Persbericht

2 november 2021 · DuPont Reports Third Quarter 2021 Results · Persbericht

2 november 2021 · DuPont Announces Strategic Actions to Enhance Portfolio for Near and Long-term Value Creation · Persbericht

25 mei 2021 · Fortify and Rogers Corporation Partner to Develop 3D Printed Dielectric Material Systems for Radio Frequency Devices · Persbericht

Mijn selecties